SGTX — Sigilon Therapeutics Share News
0.000.00%
Last trade - 00:00- $56.50m
- $17.21m
- $12.94m
Brief: Sigilon Therapeutics Inc - Got Notice From Nasdaq Notifying That Co Did Not Satisfy Certain Continued Listing Requirement
Sigilon Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Sigilon Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Sigilon Therapeutics Files For Mixed Shelf Of Up To $50 Mln
Sigilon Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
U.S. RESEARCH ROUNDUP-Coupa Software, Entergy, Nektar Therapeutics
Sigilon Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Sigilon Therapeutics Posts Q4 Loss Per Share of $0.55
Brief: Sigilon Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results
Brief: Sigilon Therapeutics Appoints Sarah Yuan, Ph.D., As Chief Technical Operations Officer
Brief: Sigilon Therapeutics Inc - On Feb 18, Board Appointed Josias Fantato De Pontes As The Co's Acting Chief Financial Officer And Treasurer
Brief: Sigilon Therapeutics Announces Strategic Reprioritization
Brief: Sigilon Therapeutics Sees $1.8 Million Charges Mainly For Employee Severance And Benefit Costs
U.S. RESEARCH ROUNDUP-Ayala Pharmaceuticals, Falcon Minerals, Zoom Video Communications
U.S. STOCKS ON THE MOVE-Euroseas Ltd, iBio, Berry Global, Chegg
U.S. STOCKS ON THE MOVE-Moderna, Adagio, Krystal Biotech, Fennec Pharma
Sigilon Therapeutics slides on more bad news from on-hold drug trial
Brief: Sigilon Therapeutics Announces Update On SIG-001 Phase 1/2 Study In Hemophilia A
Brief: Sigilon Therapeutics Posts Q3 Loss Per Share Of $0.63